Overview Ever since their discovery, advanced cases of cholangiocarcinoma and gallbladder cancers have been a big issue for doctors to manage. Since these cancers only present with symptoms when the…
Overview Over the past few years, researchers have been trying to find new treatment protocols for colorectal cancer by combining anticancer drugs. Fortunately, these efforts seem to be yielding some…
Overview The FDA has granted a Fast Track Designation to the novel MDM2-p53 inhibitor named “Alrizomadlin” (APG-115) for the treatment of patients with unresectable or metastatic melanoma that is either…
Overview Based on its potential to prolong overall survival in patients with Glioblastoma, GBM, Berubicin was granted Fast Track Designation by the American Food and Drug Administration, the FDA, for…
About the FDA decision in Cervical Cancer The Food and Drug Administration, the FDA, has granted an accelerated approval to Tivdak (Tisotumab Vedotin-tftv) for the treatment of patients with recurrent…
Overview Nasopharyngeal carcinoma is a malignant tumor that affects the head and neck. Typically, this cancer starts in the upper part of the throat and spreads from there. Unfortunately, metastatic…
He is our client, a charming 58 year old man and has colorectal cancer with liver metastases. He received the standard protocol until he reached out to us and then…
Overview Melanoma is a unique type of skin cancer that originates from cells known as melanocytes. The main function of these cells is to produce a substance called melanin, which…
Background: The approval of Libtayo (Cemiplimab-rwlc) by the FDA has marked the start of a new drug protocol that can help lung cancer patients. This is a huge breakthrough in…
Straight to the Point in Triple Negative Breast Cancer Leronlimab (PRO 140) has demonstrated promising preliminary results in a phase 1b/2 clinical trial (NCT03838367) for patients with metastatic triple negative…